Active Ingredient(s): Betaxolol
FDA Approved: * October 27, 1989
Pharm Company: * SANOFI AVENTIS US
Category: Blood Pressure

Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma.[1] Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affinity for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pressure within the eye (intraocular pre... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Kerlone 10 mg Oral Tablet
NDC: 0025-5101
Sanofi-aventis U.S. LLC
Kerlone 20 mg (Betaxolol 17.88 mg) Oral Tablet
NDC: 0025-5201
Sanofi-aventis U.S. LLC

Related Brands

Drugs with the same active ingredients